SBIR/STTR Research Award

STERILIZING MEDICAL DEVICES WITH ATMOSPHERIC PLASMA

Award identifier 512903153319f9d82196907031b1651980ba050ae1031f9156e9a314ec21903cAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Atmospheric Glow Technologies
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (Verbatim from Applicant's Abstract): Atmospheric Glow Technologies, Inc. will investigate the efficacy of the patented One Atmosphere Uniform Glow Discharge Plasma (OAUGDP) in sterilizing medical devices and instruments. The OAUGDP has been shown to sterilize various surfaces against a number of microorganisms including viruses and spores. The use of atmospheric plasma to sterilize/decontaminate medical devices is, therefore, a new application of a proven baseline technology. Our goal is to develop and fabricate a prototype that will be commercially viable. We propose to inoculate stainless steel conventional surgical instruments with vegetative bacteria or spores and assess the conditions required to achieve sterilization of these devices. Currently available sterilization technologies have failed to consistently demonstrate sterilization success in rigid narrow-lumened instruments particularly against a challenge of organic debris. For this reason, we also propose to investigate the ability of OAUGDP to sterilize conventional and rigid lumened devices in the presence and absence of a protein and salt challenge. Preliminary evaluation of instrument surface changes will be made using SEM. Phase II work would include sterilization of flexible lumens, toxicity studies on potential instrument residues and further examination of any instrument surface alterations. Phase II efforts would also involve characterizing the active species generated by the OAUGDP. PROPOSED COMMERCIAL APPLICATION: The OAUGDP technology is a new sterilization/decontamination process. Samples are sterilized within seconds to several minutes at room temperature, without production of harmful byproducts or batch processing. The technology is relatively inexpensive and can be engineered in several configurations. Such a device would fulfill a market niche in hospitals, physician and dental offices, to name a few.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.